(Q80238326)
Statements
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents (English)
Laure Brulhart
Diego Kyburz
Silvia Dehler
Sylvie Revaz
Jean Dudler
Cem Gabay
Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis